Patent · US Active

Compounds and methods for kinase modulation, and indications therefor

US10829484B2 · kind B2 · utility

3Cited by
52References
21Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 27, 2016
Grant dateNov 10, 2020
Priority date—
Expiry dateNov 23, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D498/04
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Compounds of Formula I: or a pharmaceutically acceptable salt, a solvate, a tautomer, an isomer or a deuterated analog thereof, wherein A, J, R1, R2, R3, R4, R5, R6, R7, R9, X, m and n are as described herein, compositions thereof, and methods and uses thereof.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.